Hitachi Chemical and Hitachi Chemical Research Center have been awarded US Patent No. 9,458,496, "Method of characterizing vascular diseases."
Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.
US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.
The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.
In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.
This webinar will present data from the FLAURA trial and show the clinical utility of liquid biopsy in identifying non-small-cell lung cancer (NSCLC) patients who may benefit from targeted TKI therapies.
This webinar will discuss how ultra-highly sensitive and customizable targeted next-generation sequencing panels are applied in inherited disease research.